Wealth Enhancement Advisory Services’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$349K Buy
15,409
+6,129
+66% +$221K ﹤0.01% 3055
2026
Q1
$114K Buy
9,280
+4,786
+106% +$195K ﹤0.01% 3290
2025
Q4
$205K Buy
4,494
+863
+24% +$37.5K ﹤0.01% 3256
2025
Q3
$167K Buy
+3,631
New +$188K ﹤0.01% 3200

Other funds holding CNMD

Wealth Enhancement Advisory Services's CNMD Position: Q2 2026 in Review

Wealth Enhancement Advisory Services increased its CONMED (CNMD) stake by 66% in Q2 2026, buying an estimated $221K and bringing the position to 15,409 shares worth $349K. The position accounts for ﹤0.01% of the portfolio, ranked #3055.

Wealth Enhancement Advisory Services first reported a position in CNMD in Q3 2025 and has held it in 4 quarters since. 33 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

  • Wealth Enhancement Advisory Services held 15,409 shares of CONMED worth $349K as of Q2 2026.
  • Wealth Enhancement Advisory Services bought 6,129 CONMED shares in Q2 2026, an estimated $221K.
  • CONMED made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #3055 holding.
  • Wealth Enhancement Advisory Services first reported a position in CONMED in Q3 2025 and has held it in 4 quarters since.
  • 33 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.